IO Biotech Inc.

NASDAQ: IOBT · Real-Time Price · USD
2.15
0.87 (67.97%)
At close: Aug 15, 2025, 3:59 PM
1.99
-7.40%
After-hours: Aug 15, 2025, 07:58 PM EDT

IO Biotech Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
60.03M 143.19M 142.59M 211.53M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
n/a n/a 268K 268K
Other Long-Term Assets
385K 357K 84K 127K
Receivables
1.13M 1.13M 1.53M 2.09M
Inventory
n/a n/a -1.53M -2.09M
Other Current Assets
803K 754K 685K 149K
Total Current Assets
64.95M 147.25M 148.22M 221.74M
Property-Plant & Equipment
2.36M 3.11M 3.23M 155K
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
2.75M 3.46M 3.59M 550K
Total Assets
67.7M 150.72M 151.81M 222.29M
Account Payables
4.66M 3.88M 4M 3.93M
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
717K n/a 515K n/a
Other Current Liabilities
5.04M 5.03M 3.78M 461K
Total Current Liabilities
19.49M 15.72M 10.68M 10.3M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a 59K
Total Long-Term Liabilities
1.2M 1.84M 2.27M 59K
Total Liabilities
20.68M 17.56M 12.95M 10.36M
Total Debt
1.92M 2.49M 2.79M n/a
Common Stock
66K 66K 29K 29K
Retained Earnings
-359.31M -263.82M -177.74M -106.28M
Comprehensive Income
-6.85M -9.67M -10.14M -1.49M
Shareholders Equity
47.02M 133.16M 138.85M 211.92M
Total Investments
n/a 268K 268K 268K